Forbes  Oct 8  Comment 
Just four trips on average to the doctor’s office aren’t enough to put a dent in rising U.S. health care costs when compared to other wealthy countries that have lower rates of obesity and other chronic conditions that need medical attention,...
Benzinga  Oct 5  Comment 
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a biopharmaceutical company with a focus on developing innovative therapies for patients with debilitating diseases, today announced the publication of preclinical data that provide insight into the...
MedPage Today  Oct 3  Comment 
(MedPage Today) -- This weeks topics include calcium supplements, chemotherapy during pregnancy, cardiometabolic impact of obesity in children, and a low-nicotine cigarette
New York Times  Oct 2  Comment 
The soda industry has won local battles against taxes intended to counteract obesity, but as sales slump, it is losing the war of public opinion.
Forbes  Oct 1  Comment 
A new study looks at the risks of extreme obesity in children.
MedPage Today  Sep 30  Comment 
(MedPage Today) -- Updates from the Heart Failure Society of America meeting
Clusterstock  Sep 30  Comment 
America may be the world's leader in the obesity epidemic , but it's not the leader in the amount of fat we eat. In terms of overall fat consumption, we're ranked 12th on a list of the top 20 countries who eat the most fat, according to a...
Benzinga  Sep 30  Comment 
Zafgen, Inc. (Nasdaq: ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today announced that the European Commission (EC) has granted...
New York Times  Sep 28  Comment 
A soft-drink company’s philanthropy wins it praise despite its sugary contribution to obesity in America.
GenEng News  Sep 24  Comment 
Intarcia Therapeutics said today it will acquire Phoundry Pharmaceuticals for an undisclosed price, in a deal the buyer said will enhance its internal efforts to build upon the clinical success of its Phase III GLP-1 therapy ITCA 650. Phoundry...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki